Table of Content

1 Prokinetic Drug Market Overview
1.1 Product Overview and Scope of Prokinetic Drug
1.2 Prokinetic Drug Segment by Type
1.2.1 Global Prokinetic Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Metoclopramide
1.2.3 Domperidone
1.2.4 Cisapride
1.2.5 Others
1.3 Prokinetic Drug Segment by Application
1.3.1 Prokinetic Drug Sales Comparison by Application: (2021-2027)
1.3.2 Gastroparesis
1.3.3 Constipation
1.3.4 Reflux Esophagitis
1.3.5 Functional Dyspepsia
1.4 Global Prokinetic Drug Market Size Estimates and Forecasts
1.4.1 Global Prokinetic Drug Revenue 2016-2027
1.4.2 Global Prokinetic Drug Sales 2016-2027
1.4.3 Prokinetic Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Prokinetic Drug Market Competition by Manufacturers
2.1 Global Prokinetic Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Prokinetic Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Prokinetic Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Prokinetic Drug Manufacturing Sites, Area Served, Product Type
2.5 Prokinetic Drug Market Competitive Situation and Trends
2.5.1 Prokinetic Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prokinetic Drug Players Market Share by Revenue
2.5.3 Global Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Prokinetic Drug Retrospective Market Scenario by Region
3.1 Global Prokinetic Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Prokinetic Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Prokinetic Drug Market Facts & Figures by Country
3.3.1 North America Prokinetic Drug Sales by Country
3.3.2 North America Prokinetic Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prokinetic Drug Market Facts & Figures by Country
3.4.1 Europe Prokinetic Drug Sales by Country
3.4.2 Europe Prokinetic Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prokinetic Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Prokinetic Drug Sales by Region
3.5.2 Asia Pacific Prokinetic Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Prokinetic Drug Market Facts & Figures by Country
3.6.1 Latin America Prokinetic Drug Sales by Country
3.6.2 Latin America Prokinetic Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prokinetic Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Prokinetic Drug Sales by Country
3.7.2 Middle East and Africa Prokinetic Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Prokinetic Drug Historic Market Analysis by Type
4.1 Global Prokinetic Drug Sales Market Share by Type (2016-2021)
4.2 Global Prokinetic Drug Revenue Market Share by Type (2016-2021)
4.3 Global Prokinetic Drug Price by Type (2016-2021)

5 Global Prokinetic Drug Historic Market Analysis by Application
5.1 Global Prokinetic Drug Sales Market Share by Application (2016-2021)
5.2 Global Prokinetic Drug Revenue Market Share by Application (2016-2021)
5.3 Global Prokinetic Drug Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Sumitomo
6.1.1 Sumitomo Corporation Information
6.1.2 Sumitomo Description and Business Overview
6.1.3 Sumitomo Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sumitomo Product Portfolio
6.1.5 Sumitomo Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Johnson & Johnson Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Kyowa Kirin Pharmaceuticals
6.4.1 Kyowa Kirin Pharmaceuticals Corporation Information
6.4.2 Kyowa Kirin Pharmaceuticals Description and Business Overview
6.4.3 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Kyowa Kirin Pharmaceuticals Product Portfolio
6.4.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Teva Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Cadila Pharmaceuticals
6.6.1 Cadila Pharmaceuticals Corporation Information
6.6.2 Cadila Pharmaceuticals Description and Business Overview
6.6.3 Cadila Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cadila Pharmaceuticals Product Portfolio
6.7.5 Cadila Pharmaceuticals Recent Developments/Updates
6.8 Hanmi Pharm
6.8.1 Hanmi Pharm Corporation Information
6.8.2 Hanmi Pharm Description and Business Overview
6.8.3 Hanmi Pharm Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Hanmi Pharm Product Portfolio
6.8.5 Hanmi Pharm Recent Developments/Updates

7 Prokinetic Drug Manufacturing Cost Analysis
7.1 Prokinetic Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prokinetic Drug
7.4 Prokinetic Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prokinetic Drug Distributors List
8.3 Prokinetic Drug Customers

9 Prokinetic Drug Market Dynamics
9.1 Prokinetic Drug Industry Trends
9.2 Prokinetic Drug Growth Drivers
9.3 Prokinetic Drug Market Challenges
9.4 Prokinetic Drug Market Restraints

10 Global Market Forecast
10.1 Prokinetic Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prokinetic Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Prokinetic Drug by Type (2022-2027)
10.2 Prokinetic Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prokinetic Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Prokinetic Drug by Application (2022-2027)
10.3 Prokinetic Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prokinetic Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Prokinetic Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Prokinetic Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Prokinetic Drug Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Prokinetic Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Prokinetic Drug Covered in This Study
Table 5. Global Prokinetic Drug Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Prokinetic Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Prokinetic Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Prokinetic Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Prokinetic Drug Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Prokinetic Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Prokinetic Drug Product Type
Table 12. Global Prokinetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prokinetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prokinetic Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Prokinetic Drug Sales by Region (2016-2021) & (K Units)
Table 16. Global Prokinetic Drug Sales Market Share by Region (2016-2021)
Table 17. Global Prokinetic Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Prokinetic Drug Sales by Country (2016-2021) & (K Units)
Table 19. North America Prokinetic Drug Sales Market Share by Country (2016-2021)
Table 20. North America Prokinetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Prokinetic Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Prokinetic Drug Sales by Country (2016-2021) & (K Units)
Table 23. Europe Prokinetic Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Prokinetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Prokinetic Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Prokinetic Drug Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Prokinetic Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Prokinetic Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Prokinetic Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Prokinetic Drug Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Prokinetic Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Prokinetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Prokinetic Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Prokinetic Drug Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Prokinetic Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Prokinetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Prokinetic Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Prokinetic Drug Sales (K Units) by Type (2016-2021)
Table 39. Global Prokinetic Drug Sales Market Share by Type (2016-2021)
Table 40. Global Prokinetic Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Prokinetic Drug Revenue Share by Type (2016-2021)
Table 42. Global Prokinetic Drug Price (US$/Unit) by Type (2016-2021)
Table 43. Global Prokinetic Drug Sales (K Units) by Application (2016-2021)
Table 44. Global Prokinetic Drug Sales Market Share by Application (2016-2021)
Table 45. Global Prokinetic Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Prokinetic Drug Revenue Share by Application (2016-2021)
Table 47. Global Prokinetic Drug Price (US$/Unit) by Application (2016-2021)
Table 48. Sumitomo Corporation Information
Table 49. Sumitomo Description and Business Overview
Table 50. Sumitomo Prokinetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Sumitomo Prokinetic Drug Product
Table 52. Sumitomo Recent Developments/Updates
Table 53. Johnson & Johnson Corporation Information
Table 54. Johnson & Johnson Description and Business Overview
Table 55. Johnson & Johnson Prokinetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Johnson & Johnson Prokinetic Drug Product
Table 57. Johnson & Johnson Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi Prokinetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Sanofi Prokinetic Drug Product
Table 62. Sanofi Recent Developments/Updates
Table 63. Kyowa Kirin Pharmaceuticals Corporation Information
Table 64. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 65. Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Kyowa Kirin Pharmaceuticals Prokinetic Drug Product
Table 67. Kyowa Kirin Pharmaceuticals Recent Developments/Updates
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Prokinetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Pfizer Prokinetic Drug Product
Table 72. Pfizer Recent Developments/Updates
Table 73. Teva Corporation Information
Table 74. Teva Description and Business Overview
Table 75. Teva Prokinetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Teva Prokinetic Drug Product
Table 77. Teva Recent Developments/Updates
Table 78. Cadila Pharmaceuticals Corporation Information
Table 79. Cadila Pharmaceuticals Description and Business Overview
Table 80. Cadila Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Cadila Pharmaceuticals Prokinetic Drug Product
Table 82. Cadila Pharmaceuticals Recent Developments/Updates
Table 83. Hanmi Pharm Corporation Information
Table 84. Hanmi Pharm Description and Business Overview
Table 85. Hanmi Pharm Prokinetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Hanmi Pharm Prokinetic Drug Product
Table 87. Hanmi Pharm Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Prokinetic Drug Distributors List
Table 91. Prokinetic Drug Customers List
Table 92. Prokinetic Drug Market Trends
Table 93. Prokinetic Drug Growth Drivers
Table 94. Prokinetic Drug Market Restraints
Table 95. Global Prokinetic Drug Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Prokinetic Drug Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Prokinetic Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Prokinetic Drug Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Prokinetic Drug Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Prokinetic Drug Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Prokinetic Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Prokinetic Drug Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Prokinetic Drug Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Prokinetic Drug Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Prokinetic Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Prokinetic Drug Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prokinetic Drug
Figure 2. Global Prokinetic Drug Market Share by Type in 2020 & 2027
Figure 3. Metoclopramide Product Picture
Figure 4. Domperidone Product Picture
Figure 5. Cisapride Product Picture
Figure 6. Others Product Picture
Figure 7. Global Prokinetic Drug Market Share by Application in 2020 & 2027
Figure 8. Gastroparesis
Figure 9. Constipation
Figure 10. Reflux Esophagitis
Figure 11. Functional Dyspepsia
Figure 12. Global Prokinetic Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Prokinetic Drug Market Size 2016-2027 (US$ Million)
Figure 14. Global Prokinetic Drug Sales 2016-2027 (K Units)
Figure 15. Global Prokinetic Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Prokinetic Drug Sales Share by Manufacturers in 2020
Figure 17. Global Prokinetic Drug Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Prokinetic Drug Players: Market Share by Revenue in 2020
Figure 19. Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Prokinetic Drug Sales Market Share by Region (2016-2021)
Figure 21. Global Prokinetic Drug Sales Market Share by Region in 2020
Figure 22. Global Prokinetic Drug Revenue Market Share by Region (2016-2021)
Figure 23. Global Prokinetic Drug Revenue Market Share by Region in 2020
Figure 24. U.S. Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Prokinetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Prokinetic Drug by Type (2016-2021)
Figure 49. Sales Market Share of Prokinetic Drug by Application (2016-2021)
Figure 50. Sales Market Share of Prokinetic Drug by Application in 2020
Figure 51. Revenue Share of Prokinetic Drug by Application (2016-2021)
Figure 52. Revenue Share of Prokinetic Drug by Application in 2020
Figure 53. Manufacturing Cost Structure of Prokinetic Drug
Figure 54. Manufacturing Process Analysis of Prokinetic Drug
Figure 55. Prokinetic Drug Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed